Presenters (from left) Sean J. Morrison, PhD, Leonard I. Zon, MD, and Iannis Aifantis, PhD, will also participate in a live panel and Q&A session on Monday on the same topics.

Presenters (clockwise, from top left): Jonathan Weissman, PhD, Karen Vousden, PhD, FAACR, Matthew Vander Heiden, MD, PhD, Melissa Davis, PhD, Mark Dawson, MD, PhD, and Zhijan James Chen, PhD.

The American Association for Cancer Research honored several cancer researchers, physician-scientists, advocates, and policymakers for their achievements during the Annual Meeting.

Annual Meeting 2021: Discovery Science Driving Clinical Breakthroughs builds on the success of past meetings and promises to deliver breakthrough scientific education and content.

The session honors Angelika Amon, PhD, with presenters (clockwise, top left): Samuel F. Bakhoum, MD, PhD, Karlene A. Cimprich, PhD, Stephen P. Jackson, PhD, and David Pellman, MD.

Program Committee Chair Charles Swanton, MBPhD, FAACR, shares some of his selections from the day’s sessions to help plan your Annual Meeting experience.

Clinical Trials Committee Co-Chair Julie Brahmer, MD, MSc, said that highlighting so many practice-changing studies demonstrates how translational the Annual Meeting and cancer research has become.

Alt’s landmark discovery of dihydrofolate reductase gene amplification provided the first molecular demonstration of genomic instability in mammalian cancer cells.

This year’s class of 25 individuals join the existing 231 distinguished scientists, clinicians, and physician-scientists who have been honored with the AACR’s highest level of recognition.

The 2021 recipients exemplify the AACR’s mission to prevent and cure all cancers through research, education, communication, collaboration, science policy, advocacy, and funding.